Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy

Author： Fumoleau P.   Giovannini M.   Rolland F.   Votan B.   Paillarse and the French Ondansetron Study Group J.M.  

Publisher： Elsevier

ISSN： 0964-1955

Source： European Journal of Cancer. Part B: Oral Oncology, Vol.33, Iss.5, 1997-09, pp. : 354-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C.   Oliver R.T.D.   Gallagher C.J.   J. O.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

Choriocarcinoma of the Gallbladder: Treated with Cisplatin-Based Chemotherapy

By Wang J.C.   Angeles S.   Chak P.   Platt A.B.   Nimmagadda N.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 165-169

Humana Press, Inc

Access to resources Recommend Favorite

Cisplatin-Based Chemotherapy for Merkel Cell Carcinoma of the Skin

By Pectasides D.   Pectasides M.   Psyrri A.   Koumarianou A.   Xiros N.   Pectasides E.   Gaglia A.   Lianos E.   Papaxoinis G.   Lampadiari V.   Economopoulos Th.  

Cancer Investigation, Vol. 24, Iss. 8, 2006-10 ,pp. : 780-785

Informa Healthcare

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 809-817

Spandidos Publications

Access to resources Recommend Favorite